Location History:
- Saskatchewan, CA (2015)
- Saskatoon, CA (2008 - 2020)
Company Filing History:
10 out of 11 
3 out of 7 
1 out of 1 Years Active: 2008-2020
Title: Dayan Goodenowe: Innovator in Cancer Diagnostics
Introduction
Dayan Goodenowe is a prominent inventor based in Saskatoon, Canada, known for his significant contributions to the field of cancer diagnostics. With a total of 15 patents to his name, Goodenowe has focused on developing innovative methods for diagnosing colorectal and ovarian cancers, as well as addressing age-related disorders.
Latest Patents
Goodenowe's latest patents include groundbreaking methods for diagnosing a colorectal cancer (CRC) health state or change in CRC health state. This invention relates to the diagnosis of colorectal and ovarian cancers through the measurement of vitamin E isoforms and related metabolites. It also addresses the early detection of CRC and monitoring the effects of therapy on CRC and OC health states. Another notable patent involves methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging. This invention highlights the relationship between plasmalogen biosynthesis dysfunction and various age-related disorders, including an increased prevalence of several types of cancer and cognitive impairments.
Career Highlights
Throughout his career, Goodenowe has worked with notable companies such as Phenomenome Discoveries Inc. and Med-Life Discoveries LP. His work has significantly advanced the understanding of cancer diagnostics and the biochemical mechanisms underlying age-related diseases.
Collaborations
Goodenowe has collaborated with esteemed colleagues, including M Amin Khan and Paul L Wood, contributing to the advancement of research in his field.
Conclusion
Dayan Goodenowe's innovative work in cancer diagnostics and age-related disorders has made a lasting impact on medical research. His patents reflect a commitment to improving health outcomes through advanced diagnostic methods.